- Infusion Pumps
- Metered Dose Inhalers
- Nebulizers
- Syringes
- Ocular Inserts
- Nasal Sprays
- Implantable Drug Delivery Devices
- Transdermal Patches
- Trans-Mucosal Drug Delivery Devices
- Others
Latin America Drug Delivery Devices Market poised to grow at a CAGR of 9.8% during the forecast period 2024 to 2030. The Latin America market provides a detailed overview and that can be segmented by product type, by route of administration, by formulation, by application, and by distribution channel. By product type, the Latin America drug delivery devices market has been segmented into infusion Pumps, Metered Dose Inhalers, Nebulizers, Syringes, Ocular Inserts, Nasal Sprays, Implantable Drug Delivery Devices, Transdermal Patches, Trans-Mucosal Drug Delivery Devices, and Others. The infusion Pumps segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. Based on route of administration, the Latin America drug delivery devices market is segmented into Oral, Parenteral, Transdermal, Trans-Mucosal, Inhalation, Ocular, and Others. Among these, the Oral segment is expected to have the fastest-growing market during the forecast period 2022-2028.
Based on formulation, the Latin America drug delivery devices market is segmented into Solid, Liquid, Semi-Solid. The Liquid segment accounts for the largest share in 2021. Hosted segment is the second-largest share during the forecast period 2022-2028. Based on the application, the segment has been segregated into Diabetes, Oncology, Autoimmune Disorders, Neurological Disorders, Gastrointestinal Disorders, Respiratory Disorders, and Others. The Diabetes segment is expected to dominate other segments in the Latin America drug delivery devices market. The Oncology segment is expected to witness the highest CAGR during the forecast period according to precision business insights. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The Hospital Pharmacies segment accounts for the largest share in 2021 and is anticipated to register a significant CAGR in the upcoming years.
Latin America Drug Delivery Devices Market Key Developments:
- In Oct 2022, Merck KGaA extended its collaboration with Biocorp to develop a version of a Bluetooth enabled clip-on device that is specific to one of its drug delivery devices. In Oct 2022, Eisai started work on $69M injectable drug delivery facility.
Latin America Drug Delivery Devices Market Dynamics
Increase in the prevalence of chronic diseases such as diabetes and cancer in Brazil and Mexico, adoption of newer drug delivery devices and expansion of business by market players, rise in awareness about self-injector devices and development in economic growth are anticipated to propel the market growth over the forecast years.
Country Analysis
By country, the Brazil is expected to witness the highest market share during the forecast period it holds a tremendous potential market for Latin America drug delivery devices.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Latin America Drug Delivery Devices Market Segmentation
By Product Type
By Route Administration
- Oral
- Parenteral
- Transdermal
- Trans-Mucosal
- Inhalation
- Ocular
- Others
By Application
- Diabetes
- Oncology
- Autoimmune Disorders
- Neurological Disorders
- Gastrointestinal Disorders
- Respiratory Disorders
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Frequently Asked Questions
The latin america drug delivery devices market is poised to grow at a CAGR of 9.8% during the forecast period 2024 to 2030.
The latin america drug delivery devices market data: latin(brazil, argentina.,mexico)
The latin america drug delivery devices market key players are becton dickinson and company hoffmann la roche ltd. smiths medical, inc. braun melsungen ag pfizer, inc. merck & co., inc. sanofi s.a. abbott laboratories novartis ag eli lilly and company
| 1.Executive Summary |
| 2. Latin America Drug Delivery Devices Market Introduction |
| 2.1. Latin America Drug Delivery Devices Market - Taxonomy |
| 2.2. Latin America Drug Delivery Devices Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Route Administration |
| 2.2.3.Application |
| 2.2.4.Distribution Channel |
| 2.2.5.Country |
| 3. Latin America Drug Delivery Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Latin America Drug Delivery Devices Market Analysis, 2019- 2023 and Forecast 2024 -2030 |
| 4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Latin America Drug Delivery Devices Market By Product Type, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 5.1. Infusion Pumps |
| 5.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Metered Dose Inhalers |
| 5.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nebulizers |
| 5.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Syringes |
| 5.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Ocular Inserts |
| 5.5.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Nasal Sprays |
| 5.6.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Implantable Drug Delivery Devices |
| 5.7.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Transdermal Patches |
| 5.8.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Trans-Mucosal Drug Delivery Devices |
| 5.9.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 5.10. Others |
| 5.10.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.10.3. Market Opportunity Analysis |
| 6. Latin America Drug Delivery Devices Market By Route Administration, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Parenteral |
| 6.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Transdermal |
| 6.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Trans-Mucosal |
| 6.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Inhalation |
| 6.5.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Ocular |
| 6.6.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7. Latin America Drug Delivery Devices Market By Application, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 7.1. Diabetes |
| 7.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Oncology |
| 7.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Autoimmune Disorders |
| 7.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Neurological Disorders |
| 7.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Gastrointestinal Disorders |
| 7.5.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Respiratory Disorders |
| 7.6.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8. Latin America Drug Delivery Devices Market By Distribution Channel, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Latin America Drug Delivery Devices Market By Country, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 9.1. Latin America |
| 9.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Brazil |
| 9.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Mexico |
| 9.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Rest of LA |
| 9.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 10.Latin America Latin America Drug Delivery Devices Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Infusion Pumps |
| 10.1.2.Metered Dose Inhalers |
| 10.1.3.Nebulizers |
| 10.1.4.Syringes |
| 10.1.5.Ocular Inserts |
| 10.1.6.Nasal Sprays |
| 10.1.7.Implantable Drug Delivery Devices |
| 10.1.8.Transdermal Patches |
| 10.1.9.Trans-Mucosal Drug Delivery Devices |
| 10.1.10.Others |
| 10.2. Route Administration Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oral |
| 10.2.2.Parenteral |
| 10.2.3.Transdermal |
| 10.2.4.Trans-Mucosal |
| 10.2.5.Inhalation |
| 10.2.6.Ocular |
| 10.2.7.Others |
| 10.3. Application Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Diabetes |
| 10.3.2.Oncology |
| 10.3.3.Autoimmune Disorders |
| 10.3.4.Neurological Disorders |
| 10.3.5.Gastrointestinal Disorders |
| 10.3.6.Respiratory Disorders |
| 10.3.7.Others |
| 10.4. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospital Pharmacies |
| 10.4.2.Retail Pharmacies |
| 10.4.3.Online Pharmacies |
| 10.4.4.Others |
| 11.Brazil Latin America Drug Delivery Devices Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Infusion Pumps |
| 11.1.2.Metered Dose Inhalers |
| 11.1.3.Nebulizers |
| 11.1.4.Syringes |
| 11.1.5.Ocular Inserts |
| 11.1.6.Nasal Sprays |
| 11.1.7.Implantable Drug Delivery Devices |
| 11.1.8.Transdermal Patches |
| 11.1.9.Trans-Mucosal Drug Delivery Devices |
| 11.1.10.Others |
| 11.2. Route Administration Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oral |
| 11.2.2.Parenteral |
| 11.2.3.Transdermal |
| 11.2.4.Trans-Mucosal |
| 11.2.5.Inhalation |
| 11.2.6.Ocular |
| 11.2.7.Others |
| 11.3. Application Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Diabetes |
| 11.3.2.Oncology |
| 11.3.3.Autoimmune Disorders |
| 11.3.4.Neurological Disorders |
| 11.3.5.Gastrointestinal Disorders |
| 11.3.6.Respiratory Disorders |
| 11.3.7.Others |
| 11.4. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospital Pharmacies |
| 11.4.2.Retail Pharmacies |
| 11.4.3.Online Pharmacies |
| 11.4.4.Others |
| 12.Mexico Latin America Drug Delivery Devices Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Infusion Pumps |
| 12.1.2.Metered Dose Inhalers |
| 12.1.3.Nebulizers |
| 12.1.4.Syringes |
| 12.1.5.Ocular Inserts |
| 12.1.6.Nasal Sprays |
| 12.1.7.Implantable Drug Delivery Devices |
| 12.1.8.Transdermal Patches |
| 12.1.9.Trans-Mucosal Drug Delivery Devices |
| 12.1.10.Others |
| 12.2. Route Administration Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oral |
| 12.2.2.Parenteral |
| 12.2.3.Transdermal |
| 12.2.4.Trans-Mucosal |
| 12.2.5.Inhalation |
| 12.2.6.Ocular |
| 12.2.7.Others |
| 12.3. Application Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Diabetes |
| 12.3.2.Oncology |
| 12.3.3.Autoimmune Disorders |
| 12.3.4.Neurological Disorders |
| 12.3.5.Gastrointestinal Disorders |
| 12.3.6.Respiratory Disorders |
| 12.3.7.Others |
| 12.4. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospital Pharmacies |
| 12.4.2.Retail Pharmacies |
| 12.4.3.Online Pharmacies |
| 12.4.4.Others |
| 13.Rest of LA Latin America Drug Delivery Devices Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Infusion Pumps |
| 13.1.2.Metered Dose Inhalers |
| 13.1.3.Nebulizers |
| 13.1.4.Syringes |
| 13.1.5.Ocular Inserts |
| 13.1.6.Nasal Sprays |
| 13.1.7.Implantable Drug Delivery Devices |
| 13.1.8.Transdermal Patches |
| 13.1.9.Trans-Mucosal Drug Delivery Devices |
| 13.1.10.Others |
| 13.2. Route Administration Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oral |
| 13.2.2.Parenteral |
| 13.2.3.Transdermal |
| 13.2.4.Trans-Mucosal |
| 13.2.5.Inhalation |
| 13.2.6.Ocular |
| 13.2.7.Others |
| 13.3. Application Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Diabetes |
| 13.3.2.Oncology |
| 13.3.3.Autoimmune Disorders |
| 13.3.4.Neurological Disorders |
| 13.3.5.Gastrointestinal Disorders |
| 13.3.6.Respiratory Disorders |
| 13.3.7.Others |
| 13.4. Distribution Channel Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospital Pharmacies |
| 13.4.2.Retail Pharmacies |
| 13.4.3.Online Pharmacies |
| 13.4.4.Others |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Becton Dickinson and Company |
| 14.2.2.Hoffmann La Roche Ltd. |
| 14.2.3.Smiths medical, Inc. |
| 14.2.4.Braun Melsungen AG |
| 14.2.5.Pfizer, Inc. |
| 14.2.6.Merck & Co., Inc. |
| 14.2.7.Sanofi S.A. |
| 14.2.8.Abbott Laboratories |
| 14.2.9.Novartis AG |
| 14.2.10.Eli Lilly and company |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Becton Dickinson and Company
- Hoffmann La Roche Ltd.
- Smiths medical, Inc.
- Braun Melsungen AG
- Pfizer, Inc.
- Merck & Co., Inc.
- Sanofi S.A.
- Abbott Laboratories
- Novartis AG
- Eli Lilly and company